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Persistent replication of coxsackievirus B4 (CVB4) E2 (diabetogenic) and CVB4 JBV (nondiabetogenic)
strains in thymic epithelial cell (TEC)-enriched cultures (>95%) was proved by detection of positive- and
negative-strand viral RNA by reverse transcription-PCR in extracted RNA from cell cultures, VP1 capsid
protein detection by immunofluorescence (IF) staining, and release of infectious particles up to 30 days after
infection without obvious cytolysis. By double-IF staining, cytokeratin-containing cells were shown to be
susceptible to CVB4. The persistence of CVB4 was associated with a significantly increased rate of TEC
proliferation (up to 70%) after 20 days of culture and a significantly increased chronic production of immu-
noreactive interleukin-6 (IL-6), leukemia inhibitory factor, and granulocyte-macrophage colony-stimulating
factor in supernatant after 3 days of culture. The CVB4 replication and the release of cytokines were not
restricted to the CVB4 E2 diabetogenic strain and did not depend on the genetic background of the host;
however, TEC were more responsive to CVB4 E2 than CVB4 JBV as far as the production of cytokines.
Environmental factors, especially virus infections, are sup-
posed to be involved in the pathophysiology of type 1 diabetes
(16). Enteroviruses of the family Picornaviridae are small, na-
ked icosahedral viruses ranged into four subgroups: poliovirus,
coxsackievirus A, coxsackievirus B (CVB), and echovirus. Ep-
idemiological studies have highlighted an association between
incidence of type 1 diabetes and recent enterovirus infections
(10). Moreover, exposure to enterovirus infection , in utero or
during childhood, increases the risk of diabetes occurrence
(17). Among enteroviruses, CVB is a possible etiological factor
in promoting -cell autoimmune destruction. The CVB ge-
nome and alpha interferon have been detected in peripheral
blood of type 1 diabetic patients (6). The CVB4 strain E2 was
isolated from the pancreas of a child who died from diabetic
ketoacidosis (32), and CVB4 E2 infection induces diabetes,
with hyperglycemia and -cell autoimmunity, in some strains
of mice (15, 26). The pathogenic mechanism by which CVB4
can contribute to the development of an autoimmune disease
like type 1 diabetes has not been elucidated. As for other
organ- or cell-specific autoimmune diseases, the development
of type 1diabetes corresponds to a loss of immune self-toler-
ance at a central and/or peripheral level (29); however, the
association between CVB4 infection and the loss of immune
self-tolerance has not been investigated.
The induction of immune self-tolerance is an active multi-
step process already initiated within the thymus network dur-
ing T-cell ontogeny (13, 14, 20). The thymus exerts a promi-
nent role in the establishment of central T-cell self-tolerance
(by clonal deletion of self-reactive T cells and generation of
regulatory CD4 CD25 cells), as well as in the development
of self major histocompatibility complex-restricted and self-
tolerant T lymphocytes (1, 25). Thymic epithelial cells (TEC)
play a critical role in the differentiation of T-cell precursors,
providing a microenvironment with a unique capacity to gen-
erate functional and self-tolerant T cells (2). Cytokines like
interleukin-6 (IL-6), leukemia inhibitory factor (LIF), and
granulocyte-macrophage colony-stimulating factor (GM-CSF)
produced by TEC in the thymus (18) play an important role in
this process. IL-6 has been demonstrated as a cofactor of
proliferation of various thymic T-cell subpopulations (11). LIF
is involved in maturation of T lymphocytes: lif/ mice are
defective in T-cell activation (30), and mice overexpressing lif
in T cells display thymic and lymph node abnormalities (28).
GM-CSF specifically activates the proliferation of immature
thymocytes (9).
A variety of different viruses can infect human thymic epi-
thelial tissue (22, 31). Because of the important role of the
thymus in establishment of self-tolerance, viral infection of
thymic tissue may play a role in the pathogenesis of autoim-
mune diseases. The role of a virus in the induction and/or
triggering of type 1 diabetes could result from interference
with the central tolerogenic role of the thymus through an
interaction between the virus and TEC. Selinka et al. pre-
sented evidence of 50-, 100-, and 120-kDa CVB-binding pro-
teins in mouse thymus (27), but nothing is known about the
susceptibility of the human thymus to CVB infection. There-
fore, in the present study, infection of human TEC primary
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cultures with CVB4 and the resulting effects on TEC function
have been investigated.
CVB4 induces a persistent infection of human TEC. Thymus
fragments were obtained from children (6 months to 3 years
old) undergoing corrective cardiovascular surgery for congen-
ital cardiopathies and processed as previously described to
isolate TEC (24). Thymus fragments were cultured for 18 days,
and then adherent confluent cells (TEC) were detached by
treatment with a solution of trypsin-Versene (EDTA) (Bio-
Whittaker, Verviers, Belgium) and filtered through nylon gaze
to eliminate explant residues. Cultured human TEC were
counted and seeded at 400,000 cells per T-25 flask (Corning,
Acton, Mass.) for the dosage of infectious viral particles in
TEC culture supernatants and cytokine assays for long periods
postinfection. Cells were seeded at 200,000 cells per well on
6-well plates for total RNA extraction and also at 3,500 and
30,000 cells per well on 96- and 24-well culture plates for the
proliferation assay and cytokine assays, respectively, in exper-
iments with different concentrations of virus.
TEC were infected with CVB4 JBV (provided by J. Almond,
Aventis Pasteur, Marcy-L’Etoile, France) and E2 strains (pro-
vided by J. W. Yoon, Julia McFarlane Diabetes Research Cen-
ter, Calgary, Alberta, Canada) propagated in Hep2 cells (Bio-
Whittaker) in Eagle’s minimal essential medium (Gibco BRL,
Life Technologies, Rockville, Md.) supplemented with 10%
decomplemented fetal calf serum and 1% L-glutamine. TEC
and Vero cell lines were inoculated with each CVB4 strain at
1 or 10 PFU/TEC and then incubated for 90 min at 37°C in a
humidified atmosphere with 5% CO2. Then, TEC cultures
were extensively washed with phosphate-buffered saline (Bio-
Whittaker) and subcultured for different periods in complete
culture medium and incubated at 37°C with 5% CO2.
To detect viral internalization and replication in TEC cul-
tures, the presence of positive and negative RNA was exam-
ined by reverse transcription-PCR (RT-PCR) at different pe-
riods after infection. Total RNA was extracted with RNeasy
mini kit (Qiagen, Valencia, Calif.) and resuspended in water
according to the manufacturer’s instructions. Then, RNA was
dosed with the RiboGreen RNA quantitation kit (Molecular
Probes, Eugene, Oreg.) and used in RT-PCR. Specific primers
for human -actin (upper, 5-CTACAATGAGCTGCGTGTG
G-3; and lower, 5-AAGGAAGGCTGGAAGAGTGC-3)
generated a 528-bp product and a 969-bp fragment if contam-
ination by genomic DNA occurred. Primers (synthesized by
Biosource, Nivelles, Belgium) used for the detection of CB4
RNAs were located within the enterovirus 5NC region, which
is highly conserved among the enterovirus serotype (upper,
5-CAAGCACTTCTGTTTCCCCGG-3; and lower, 5-ATT
GTCACCATAAGCAGCCA-3). These primers generate a
435-bp product and were previously described by Leparc et al.
(19). RT-PCRs were performed with Ready-To-Go RT-PCR
beads (Amersham Pharmacia Biotech, Roosendaal, The Neth-
erlands). In a final volume of 50 l, cDNA synthesis and
amplification from human -actin and positive CB4 RNA were
performed in a one-step reaction with 25 ng of total RNA, 1 g
of random hexamer primers, and 20 pmol of each specific
primer, according to the manufacturer’s instructions (Amer-
sham Pharmacia Biotech). Negative CB4 RNA was evidenced
in a two-step reaction. First, 25 ng of total RNA was reverse
transcribed in the presence of 20 pmol of CB4 upper primer
and then denatured for 10 min at 94°C. The PCR was carried
out in the same tube with all of the cDNA and 20 pmol of each
of the specific primers. PCR products were visualized by elec-
trophoresis on 2% agarose gel stained with 0.5 g of bromide
of ethidium chloride per ml (Gibco BRL, Life Technologies,
Rockville, Md.).
Plus and minus RNAs were detected in CVB4-infected TEC
cultures as soon as 4 h after infection and during 30 days after
infection (Fig. 1a). The ability of TEC to yield infectious viral
particles was measured by a specific infectivity assay in Vero
cells (provided by B. Rentier, University of Liege, Liege, Bel-
gium) at several intervals postinfection (p.i.) to determine the
50% tissue culture infective dose (TCID50) (Fig. 1b). CVB4 E2
and JBV infection of TEC was productive and reached 106
TCID50s/ml at 48 h p.i. Virus production was maintained
thereafter and was not stopped by serial subculture for 30 days
p.i., suggesting that CVB4 E2 and JBV replicated persistently
in human TEC. Enterovirus VP1 was also detected by immu-
nocytofluorescence in human TEC cultures as previously de-
scribed by using with monoclonal anti-viral protein 1 (VP1)
antibody (Dako, Glostrup, Denmark) (5). To identify the na-
ture of infected cells, we performed a double immunostaining
of CVB4-infected TEC cultures. Slides were incubated with
rabbit polyclonal anticytokeratin (anti-CK) antibody A575
(Dako) diluted at 1:50 overnight at 4°C. Following three
washes, fluorescein isothiocyanate (FITC)-conjugated goat an-
ti-rabbit antibody (Jackson ImmnuoResearch Laboratories,
Inc., West Grove, Pa.) was applied at a dilution of 1:50 for 1 h
at room temperature. The slides were then washed and incu-
bated with monoclonal anti-viral protein 1 (VP1) antibody
diluted at 1:20 for 2 h at room temperature. Then the slides
were washed and stained with tetramethyl rhodamine isocya-
nate (TRITC)-conjugated goat anti-mouse immunoglobulin G
antibody (Jackson ImmunoResearch Laboratories, Inc.) dur-
ing 1 h at room temperature, washed again, and mounted with
glycerol-gelatin medium, and positive cells were enumerated
with a fluorescence microscope (Olympus).
Approximately 95 to 98% of cultured cells were positive for
CK and thus were identified as TEC. After both infection with
E2 and JBV, VP1 was located in the cytoplasm of CK-positive
cells around nuclei, confirming that TEC were the VP1-pro-
ducing cells (Fig. 1c). The proportions of VP1-positive TEC
were quite stable: 5 to 10% at 24 h p.i. and 3 to 5% further in
the culture (16 days p.i. and after).
CVB4 infection enhances the proliferation of TEC. CVB4
infection did not affect the appearance of TEC by light micros-
copy after as many as 30 days. There was no significant change
in mortality between CVB4- and mock-infected TEC cultures
(5% in both conditions). Cells were harvested from CVB4-
infected or mock-infected human TEC cultures on the day of
infection and 6, 13, and 20 days p.i., and then the cells were
cultured in 96-well plates (3,000 cells/well) in octoplicate for 5
days. Every day, the cell proliferation reagent WST-1 (Roche,
Indianapolis, Ind.), which identifies living cells, was added to
the cultures, and then the cells were incubated for 4 h at 37°C
with 5% CO2. The resulting formazan dye was quantitated at
A450 to A690 with a spectrophotometer (Vmax kinetic micro-
plate reader; Molecular Devices). Optical density values ob-
tained on the day of infection and 6, 13, and 20 days p.i. were
considered as baseline. The kinetics of growth was not signif-











icantly different between TEC infected with CVB4 E2 or JBV
and mock-infected cells until 20 days p.i. (data not shown).
After this delay, the proliferation of CVB4 JBV- and E2-
infected TEC was significantly higher (20 to 70%) than that of
mock-infected cells in experiments performed with cells from
three different donors (P  0.05) (Fig. 2).
CVB4 infection modulates TEC secretion of cytokines. TEC
cultures were infected with 1 and 10 PFU of each CVB4 strain
per cell. Then, the secretion profiles of IL-6 and LIF were
investigated in TEC cultures during 168 h after infection. Spe-
cific enzyme-linked immunosorbent assays were used to mea-
sure human IL-6, LIF, and GM-CSF (BioSource Europe, Niv-
elles, Belgium) in culture supernatant samples. The assays
were performed according to the manufacturer’s instructions.
Absorbency was transformed to cytokine concentration by us-
ing a standard curve computed with BioSource enzyme-linked
immunosorbent assay software (BioSource Europe). The levels
of IL-6 and LIF in supernatants of cultures infected with CVB4
JBV at a multiplicity of infection (MOI) of 1 were not different
from those of mock-infected cultures. In contrast, in superna-
tants of cultures infected with CVB4 JBV at an MOI of 10 or
with CVB4 E2 at an MOI of 1 or 10, increased levels of IL-6
and LIF were found 96 h p.i. and thereafter compared with
mock-infected cultures (Table 1). Moreover, the levels of cy-
tokines obtained in cultures infected with CVB4 E2 at an MOI
of 1 were higher than those in cultures infected with CVB4
JBV at the same MOI (P  0.05).
When TEC were challenged for 1 h 30 min with CVB4 JBV
or CVB4 E2 (MOI of 10) and then washed and refed with
complete medium every 3 days for 30 days, continuous pro-
duction of IL-6, LIF, and GM-CSF was detected. Compared
with mock-infected cultures, the cytokine concentrations re-
mained significantly high and increased from day 3 p.i. to day
21 p.i (Fig. 3). Then the levels of IL-6, LIF, and GM-CSF in
infected-TEC cultures decreased progressively, whereas those
of mock-infected cultures were stable (data not shown).
The specificity of the CVB4 effects was checked with a neu-
tralizing polyclonal rabbit anti-CVB4 antibody (Eurobio, Les
FIG. 1. TEC infected with CVB4. (a) Agarose gel electrophoresis of amplicons specific to the positive and negative strands of the enterovirus
genome (435 bp). Strand-specific RT-PCR was carried out with 25 ng of total RNA taken from mock-infected TEC (m-i.) and CVB4E2-and
CVB4JVB-infected TEC at 0 and 4 h and at 7, 15, and 30 days p.i. H2O, negative control. Equivalent expression of -actin-specific RNA (528 bp)
was detected in all samples. The results are representative of three independent experiments. (b) Release of infectious particles by TEC infected
with CVB4 JBV and CVB4 E2. The viral titer in culture supernatants at various times p.i. was determined by the TCID50 assay with Vero cell
cultures. The means  standard deviations of three independent experiments are presented. (c) Detection of enterovirus viral protein 1 (VP1) by
IF in human TEC 24 h after infection with CVB4 E2 (A, B, and C, 200). (A) Cells indirectly stained for VP1 with TRITC-conjugated antibodies.
(B) Cells indirectly stained for CK with FITC-conjugated antibodies showing the dominant epithelial phenotype of cultures. (C) Cells double
stained for VP1 with TRITC-conjugated antibodies and for CK with FITC-conjugated antibodies. In double-stained cells, orange was observed.
Similar results were obtained with CVB4 JBV.











Ulis, France) at a dilution of 1:10. Both the CVB4 E2 and JBV
strains were blocked 90 min at 37°C before inoculation into
TEC cultures. When CVB4 E2 and JBV stock solutions used
for challenging TEC were pretreated with a neutralizing anti-
body, the enhanced production of cytokines was inhibited (Ta-
ble 2).
This study investigates the hypothesis of CVB4 infection of
human TEC primary cultures. The detection of infectious par-
ticles released in the supernatants of cultures, as well as the
presence of VP1 in cells and the presence of viral positive- and
negative-strand RNA in cultures up to 30 days p.i., demon-
strates that continuous CVB4 replication occurs in TEC cul-
tures. CVB4 predominantly replicates in TEC in our experi-
ments, as proved by the double-immunofluorescence (IF) of
CVB-infected cells with VP1 present in CK-containing cells
only and by the percentage of VP1-positive cells (10%). This
excludes the role of nonepithelial cells (1 to 5%) as major host
cells in TEC-enriched cultures in these experiments. The de-
crease in the proportion of infected cells in the course of the
culture (from 10% to 5%) may be due in part to the lysis of
some cells. However, according to the relatively low number of
infected cells, significant lysis of infected cells did not occur.
Thus, TEC cultures are capable of supporting the persistent
replication of CVB4 without obvious cytopathic effect. Our
results show that CVB4, usually described as a cytolytic virus,
can persist in certain human cell types, which is in agreement
FIG. 2. Effect of CVB4 infection on TEC proliferation. Prolifera-
tion kinetics of CVB4 E2- and CVB4 JVB-infected human TEC (MOI
of 10) from 20 days p.i. (20 dpi) to 30 days p.i. (end of the culture)
determined with a colorimetric assay. Results of three different thy-
muses in eight samplings were collected (expressed as means  stan-
dard deviations) and presented as a Boltzman sigmoidal curve. †, P 
0.05 for CVB4 E2 and JBV versus mock-infected cells (analysis of
variance followed by Student-Newman-Keuls posttests).
FIG. 3. Continuous release of IL-6, LIF, and GM-CSF in superna-
tants of TEC infected with CVB4 JBV and CVB4 E2 (MOI of 10) and
submitted to serial subculture. Cytokine levels were detected by en-
zyme-linked immunosorbent assay. The results are expressed as nano-
grams per milliliter for IL-6 and picograms per milliliter for LIF and
GM-CSF. Means  standard deviations of three independent experi-
ments are presented. , P  0.01 for CVB4 E2 and JBV versus mock-
infected cells.
TABLE 1. Levels of IL-6 and LIF in TEC cultures infected
with CVB4 E2 and JBV 168 h p.i.
Cytokine
% Cytokine levela
CVB4 E2 CVB4 JBV
MOI-1 MOI-10 MOI-1 MOI-10
IL-6 443  98.5† 391  56.3* 142  10.7 266  42.4†
LIF 207  7.0† 229  7.0* 108  6.9 172  6.7†
a Results are expressed as percentages (mean  standard error [n 	 3]), with
the cytokine levels in mock-infected cultures equivalent to 100. P  0.05 (†) or
P  0.01 (*) versus mock-infected cells.
TABLE 2. Effect of anti-CVB4-neutralizing antibody on IL-6
and LIF production by TEC 168 h p.i.
Culture type
Cytokine production with anti-CVB4 antibody
statusa:
IL-6 (ng/ml) LIF (pg/ml)
   
Mock infected 16  1 16  0.01 430  3.7 456  5
CVB4 E2 (MOI 	 10) 61  0.5* 15  0.3 1,055  1.1* 443  22.7
CVB4 JBV (MOI 	 10) 51  0.6* 22  0.3 997  83.1* 434  10
a Results are means  standard deviations (n 	 3). *, P  0.01 versus mock-
infected cells.











with previous in vitro studies of CVB infection of vascular
endothelial cells (7, 8) and pancreatic -cells (5). Our data
suggest that the persistence of CVB4 in TEC cultures is prob-
ably established through the mechanism of the carrier-state
culture as previously reported for other cell types (8).
A relatively small proportion of TEC containing viral pro-
teins was detected by IF in the earlier stages of infection
(10% at 24 h p.i.) and during chronic infection ( 5%).
These data suggest that there is heterogeneity in the suscepti-
bility of TEC to CVB4 infection, which can be due to the
presence of TEC subpopulations in the cultures (insofar as
TEC are derived from both thymic cortex and medulla with a
predominant medullary origin), or to the metabolic heteroge-
neity of these cells (12, 24). Further experiments are needed to
clarify the mechanisms of TEC susceptibility to CVB4.
Human TEC can be infected with different viruses in vitro.
Certain human immunodeficiency virus type 1 strains and iso-
lates induce a productive and persistent infection in TEC with-
out damaging the cells, which is consistent with the CVB4
infection of TEC observed in our studies (3). In the case of
cytomegalovirus and measles virus, a persistent infection can
be obtained, but morphological changes appear (22). Also, in
the case of herpes simplex virus type 2 and adenovirus 7, an
obvious cytopathic effect was induced (31). CVB4 replicated in
TEC cultures, but it was not cytotoxic. In contrast, compared
with mock-infected cells, an increased proliferation rate was
observed in CVB4-infected cultures 20 days after infection.
The predominant cells in these cultures were TEC, as proved
by the high percentage of CK-containing cells by IF staining
(
90%), which excludes the role of non-TEC-contaminating
cells (10% of the cells) as major proliferating cells in these
experiments. Several factors may be responsible for the initi-
ation of increased TEC proliferation in CVB4-infected cul-
tures. The increased production of cytokines in CVB4-infected
TEC cultures observed in the present study suggests that virus-
induced factors can play a role. Whether viral components
and/or virus-induced growth factors are involved in this phe-
nomenon remains to be determined.
The CVB4 JBV strain was capable of infecting and replicat-
ing in human TEC from three different donors with the same
intensity as the CVB4 diabetogenic E2 strain did. No signifi-
cant difference was detected in levels of cytokines induced by
these virus strains at an MOI of 10, but the level of cytokines
induced by CVB4 E2 at an MOI of 1 was significantly higher
than that induced by CVB4 JBV at the same MOI. Thus, the
viral replication and production of cytokines in TEC cultures
were not restricted to the CVB4 E2 diabetogenic strain and did
not depend on the genetic background of the host. However, as
far as the production of cytokines is concerned, TEC were
more responsive to CVB4 E2 than CVB4 JBV. The precise
mechanism remains to be elucidated; however, the capability
to increase the production of cytokines in the case of CVB4
JBV and CVB4 E2 is reminiscent of the findings in other
reports. Indeed, with poliovirus strains, members of the en-
terovirus group like CVB, it has been demonstrated that wild-
type or neurovirulent strains were better interferon inducers
than attenuated strains (23).
Our data confirm previous observations that TEC spontane-
ously produce cytokines in vitro (18, 21) and that viruses can
modulate the production of cytokines by TEC, without a virus-
induced cytopathic effect (31). However, our study is different
from those of other investigators, because we report a signifi-
cantly increased production of IL-6, LIF, and GM-CSF by
TEC in response to CVB4 and because CVB4 replication was
investigated at the molecular level. Indeed, the continuous
increased cytokine production observed in the course of the
culture of CVB4-infected TEC (up to 30 days) was correlated
with the detection of VP1, viral RNA (positive and negative
strands) in the cells, and viral progeny in culture supernatants,
and the increased production of cytokines was inhibited by pre-
treatment of the virus with neutralizing antiserum against CVB4.
Together, these data show that the persistent replication of CVB4
in TEC results in increased production of cytokines by these cells.
Due to the increased rate of proliferation, infected TEC were
confluent at 21 days p.i. in our experiments, whereas mock-in-
fected TEC were not confluent up to 30 days p.i. That difference
can explain the decreased levels of cytokines in infected cultures
at 21 days p.i., whereas the values were lower, but remained
unchanged in mock-infected cultures up to 30 days p.i.
Diabetogenic CVB4 can reach the thymus in the course of
systemic infection of mice, which results in a significant in-
crease in CD4 CD8 thymic T lymphocytes together with
insulitis and hyperglycemia (4). The nature of infected cells
within the thymus was not elucidated in the previous study, but
these data suggest that CVB4 can induce abnormal T-lympho-
cyte maturation, which may contribute to development of di-
abetes. Studies are in progress in our laboratory to investigate
whether, in vivo, CVB4 can infect the epithelial network of the
thymus, as suggested by our in vitro studies. It will be of
interest to investigate whether CVB4-infected TEC and the
resulting increase in cytokine levels in the microenvironment
of TEC play a role in the impairment of central T-cell self-
tolerance. In our laboratory, future studies will be directed
along this line to provide better knowledge about the patho-
genesis of CVB4-induced diabetes type 1.
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